Testers rated intake, pricing and support at each telehealth service. Fortune notes many also sell compounded GLP-1s the FDA hasn't approved.
Recap by typeshit. Full story at Fortune.
Canada is one of the first big markets where semaglutide goes off patent. IQVIA plans ongoing updates on pricing, coverage and generic uptake.
The Medicare GLP-1 Bridge pilot runs July 2026 through 2027, covering FDA-approved pills and shots with no deductible for eligible Part D enrollees.
The two drugs brought in $14.9 billion of Lilly's $23.0 billion fiscal Q2 revenue while US prices fell 9%, Trefis says. The Q3 report is expected around October 29.
Novo Nordisk is lowering what Wegovy costs in China, a fresh move in the race for the country's obesity drug market. No figures were given.
Speaking with LCGC, Alvarez explains why a single sharp peak can mask isomers that mass spec misses, and how a second separation exposes them.
ANZCA points to a UK study of 47,000 patients finding GLP-1 users had 11 times the risk of regurgitation or aspiration under general anaesthetic.
Loading…